All News #Library
Biotech
Centessa Pharma Unveils Expanded Data on OX2R Agonist at ACNP
14 Jan 2026 //
GLOBENEWSWIRE
Centessa Pharma Updates Q3 2025 Financials, Progresses
05 Nov 2025 //
GLOBENEWSWIRE
Centessa drops hemophilia B drug following Pfizer’s Hympavzi win
13 Nov 2024 //
FIERCE BIOTECH
Centessa to Present Data from Third Year of Phase 2a Study of SerpinPC
09 Feb 2024 //
GLOBENEWSWIRE
Centessa Pharmaceuticals Announces New Data from Phase 2a Study of SerpinPC
10 Dec 2023 //
GLOBENEWSWIRE
Centessa to Present Data from Third Year of Ongoing Phase 2a Study of SerpinPC
02 Nov 2023 //
GLOBENEWSWIRE
Centessa Announces Dosing of First Subject in Study Evaluating SerpinPC
31 Oct 2023 //
GLOBENEWSWIRE
Centessa Receives Fast Track Designation from FDA for SerpinPC for Hemophilia B
22 May 2023 //
GLOBENEWSWIRE
Centessa to Present Data from OLE of Ph2a of SerpinPC for Hemophilia at EAHAD
06 Feb 2023 //
GLOBENEWSWIRE

Market Place
Sourcing Support